Lumosa Therapeutics Co., Ltd

Shanghai Lumosa Therapeutics Co., Ltd.

Eu Sol Biotech Co., Ltd.

Jin-Ding Huang

David Chih-Kuang Chou

Shu-Wen Kuo

Yu-En Tien

Chan-Jung Li

Shin-Jr Tsai

Wan-Ya Chang

Che-Ming Yeh

Shin Tsai

The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester

Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.

Use of recombinant protein for treating metabolic disorders

Growing community of inventors

Taipei, Taiwan

Jin-Ding Huang